[go: up one dir, main page]

PL1824479T3 - Pochodne fenylopiperazyny o połączonym działaniu częściowego agonisty receptora dopaminowego D2 i hamowania wychwytu zwrotnego serotoniny - Google Patents

Pochodne fenylopiperazyny o połączonym działaniu częściowego agonisty receptora dopaminowego D2 i hamowania wychwytu zwrotnego serotoniny

Info

Publication number
PL1824479T3
PL1824479T3 PL05816322T PL05816322T PL1824479T3 PL 1824479 T3 PL1824479 T3 PL 1824479T3 PL 05816322 T PL05816322 T PL 05816322T PL 05816322 T PL05816322 T PL 05816322T PL 1824479 T3 PL1824479 T3 PL 1824479T3
Authority
PL
Poland
Prior art keywords
serotonin reuptake
combination
reuptake inhibition
phenylpiperazine derivatives
receptor agonism
Prior art date
Application number
PL05816322T
Other languages
English (en)
Inventor
Roelof W Feenstra
Axel Stoit
Jan-Willem Terpstra
Maria L Pras-Raves
Andrew C Mccreary
Vliet Bernard J Van
Mayke B Hesselink
Cornelis G Kruse
Scharrenburg G J M Van
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of PL1824479T3 publication Critical patent/PL1824479T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL05816322T 2004-12-08 2005-12-06 Pochodne fenylopiperazyny o połączonym działaniu częściowego agonisty receptora dopaminowego D2 i hamowania wychwytu zwrotnego serotoniny PL1824479T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63407404P 2004-12-08 2004-12-08
EP04106394 2004-12-08
EP05816322A EP1824479B1 (en) 2004-12-08 2005-12-06 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition
PCT/EP2005/056507 WO2006061378A1 (en) 2004-12-08 2005-12-06 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition

Publications (1)

Publication Number Publication Date
PL1824479T3 true PL1824479T3 (pl) 2009-04-30

Family

ID=35744728

Family Applications (2)

Application Number Title Priority Date Filing Date
PL05850037T PL1827427T3 (pl) 2004-12-08 2005-12-06 Pochodne aryloksyetyloamin i fenylopiperazyn wykazujące połączenie częściowego agonizmu wobec receptorów dopaminowych D2 oraz hamowania wychwytu zwrotnego serotoniny
PL05816322T PL1824479T3 (pl) 2004-12-08 2005-12-06 Pochodne fenylopiperazyny o połączonym działaniu częściowego agonisty receptora dopaminowego D2 i hamowania wychwytu zwrotnego serotoniny

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL05850037T PL1827427T3 (pl) 2004-12-08 2005-12-06 Pochodne aryloksyetyloamin i fenylopiperazyn wykazujące połączenie częściowego agonizmu wobec receptorów dopaminowych D2 oraz hamowania wychwytu zwrotnego serotoniny

Country Status (18)

Country Link
EP (4) EP1824479B1 (pl)
JP (4) JP2008537725A (pl)
KR (4) KR20070085916A (pl)
AT (2) ATE413173T1 (pl)
AU (4) AU2005313391A1 (pl)
BR (1) BRPI0518613A2 (pl)
CA (4) CA2587559A1 (pl)
DE (2) DE602005010902D1 (pl)
DK (2) DK1827427T3 (pl)
ES (2) ES2311245T3 (pl)
HR (2) HRP20080538T3 (pl)
IL (4) IL183062A0 (pl)
NO (4) NO20072981L (pl)
PL (2) PL1827427T3 (pl)
PT (2) PT1824479E (pl)
RU (4) RU2007125661A (pl)
SI (2) SI1827427T1 (pl)
WO (4) WO2006061378A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007085651A1 (en) * 2006-01-30 2007-08-02 Speedel Experimenta Ag Process for the stereoselective preparation of alcohols from alpha, beta- insaturated compounds
US8063062B2 (en) 2006-12-20 2011-11-22 Solvay Pharmaceuticals B.V. Compounds with a combination of cannabinoid-CB1 antagonism and acetylcholinesterase inhibition
EA200970672A1 (ru) * 2007-01-10 2010-02-26 Солвей Фармасьютикалс Б.В. Соединения с комбинацией каннабиноид-свантагонизма и ингибирования обратного захвата серотонина
US8138174B2 (en) 2007-01-10 2012-03-20 Solvay Pharmaceuticals B.V. Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition
CA2682671C (en) * 2007-04-23 2015-11-17 Janssen Pharmaceutica N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
WO2008128994A1 (en) * 2007-04-23 2008-10-30 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
DK2148873T3 (da) * 2007-04-23 2012-11-26 Janssen Pharmaceutica Nv 4-alkoxypyridazinderivater som hurtigt dissocierende dopamin 2- receptorantagonister
CN103360342B (zh) * 2012-04-09 2015-12-16 江苏恩华药业股份有限公司 3-氰基苯胺烷基芳基哌嗪衍生物及在制备药物中的应用
CN103570698B (zh) * 2012-08-01 2016-08-03 江苏恩华药业股份有限公司 用于制备维拉佐酮的化合物及其中间体和应用
ITMI20130392A1 (it) * 2013-03-15 2014-09-16 Dipharma Francis Srl Sintesi di un inibitore della ricaptazione della serotonina
AU2014282769A1 (en) 2013-06-21 2015-12-17 Lupin Limited Substituted heterocyclic compounds as CRAC modulators
CA2914415A1 (en) 2013-06-24 2014-12-31 Lupin Limited Chromane and chromene derivatives and their use as crac modulators
EP3027607B1 (en) 2013-07-29 2020-08-26 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
EP0900792B1 (en) * 1997-09-02 2003-10-29 Duphar International Research B.V Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists
CA2327359A1 (en) * 1998-04-08 1999-10-14 Wyeth N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents)
HUP0101475A3 (en) * 1998-06-19 2003-01-28 Lundbeck & Co As H 4,5,6 and 7-indole and indoline derivatives, their preparation and use
AR022303A1 (es) * 1999-01-22 2002-09-04 Lundbeck & Co As H Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion
ATE299142T1 (de) * 1999-08-23 2005-07-15 Solvay Pharm Bv Phenylpiperazin-derivate als inhibitoren der serotonin-wiederaufnahme
CN1723209A (zh) * 2002-12-10 2006-01-18 默克专利有限公司 吲哚衍生物以及它们作为5－ht配体的应用

Also Published As

Publication number Publication date
ATE413173T1 (de) 2008-11-15
AU2005313312A1 (en) 2006-06-15
JP2008537725A (ja) 2008-09-25
HRP20080538T3 (en) 2008-12-31
CA2587381A1 (en) 2006-06-15
IL183063A0 (en) 2007-09-20
PT1827427E (pt) 2008-11-03
JP2008523029A (ja) 2008-07-03
AU2005313390A1 (en) 2006-06-15
KR20070085975A (ko) 2007-08-27
DK1827427T3 (da) 2008-11-24
NO20072977L (no) 2007-09-05
DK1824479T3 (da) 2009-03-09
KR20070085916A (ko) 2007-08-27
WO2006061377A1 (en) 2006-06-15
RU2007125659A (ru) 2009-01-20
RU2007125661A (ru) 2009-01-20
EP1827426A1 (en) 2007-09-05
PL1827427T3 (pl) 2009-01-30
RU2007125660A (ru) 2009-01-20
DE602005010902D1 (de) 2008-12-18
CA2587202A1 (en) 2006-06-15
AU2005313311A1 (en) 2006-06-15
WO2006061379A1 (en) 2006-06-15
EP1827427B1 (en) 2008-07-23
IL183064A0 (en) 2007-09-20
HRP20090015T3 (en) 2009-02-28
SI1824479T1 (sl) 2009-04-30
CA2587559A1 (en) 2006-06-15
KR20070085988A (ko) 2007-08-27
EP1827427A1 (en) 2007-09-05
WO2006061376A1 (en) 2006-06-15
BRPI0518613A2 (pt) 2008-11-25
JP2008523031A (ja) 2008-07-03
EP1824479B1 (en) 2008-11-05
EP1824479A1 (en) 2007-08-29
DE602005008471D1 (de) 2008-09-04
KR20070085959A (ko) 2007-08-27
IL183061A0 (en) 2007-09-20
WO2006061378A1 (en) 2006-06-15
SI1827427T1 (sl) 2008-12-31
AU2005313391A1 (en) 2006-06-15
ATE401883T1 (de) 2008-08-15
EP1824480A1 (en) 2007-08-29
ES2317335T3 (es) 2009-04-16
PT1824479E (pt) 2009-01-30
JP2008523030A (ja) 2008-07-03
NO20072981L (no) 2007-09-05
CA2587357A1 (en) 2006-06-15
RU2007125658A (ru) 2009-01-20
IL183062A0 (en) 2007-09-20
NO20072974L (no) 2007-08-23
ES2311245T3 (es) 2009-02-01
NO20072969L (no) 2007-08-31

Similar Documents

Publication Publication Date Title
IL183064A0 (en) Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition
SG151254A1 (en) Substituted morpholine and thiomorpholine derivatives
CY1108230T1 (el) Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MX2009003713A (es) Inhibidor de progresion de enfermedad de alzheimer que contiene un compuesto heterociclico con estructura especifica.
TW200745122A (en) New compounds I
WO2007017728A3 (en) Novel heterocyclic compounds
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
TW200745133A (en) New compounds II
TW200640898A (en) Anethole dithiolethione and other dithiolethiones for the treatment of conditions associated with dysfunction of monoamine neurotransmission
TW200716555A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
WO2007004041A3 (en) New compounds and their pharmaceutical use
TW200631952A (en) Benzdioxan piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
TW200633987A (en) Phenylpiperazines with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
TW200634009A (en) Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
NO20073390L (no) Fenylpiperaziner med en kombinasjon av affinitet for dopamin-D2-reseptorer og serotoningjenopptaksseter
HK1136288A1 (pl)
CY1106649T1 (el) Νεα 1-μεθοξυ-2-φαινυλ-αιθενια χρησιμα δια την παρασκευην 5-καρβοξαλδεϋδο-2,3-διϋδροβενζοξεπινων
TW200716565A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents